Adamax and Semax are peptides which are the subject of experimental research into synthetic peptides, but they should not be regarded as equivalent substances. The different structures of the peptides and the various modifications can affect properties including molecular interactions, proteolytic stability, and their behavior in specified laboratory conditions.
Semax is fairly well described in the scientific literature, whereas Adamax has considerably less peer-reviewed research associated with it by that name. This difference in the amount of available evidence is important when the two substances are compared scientifically.
Adamax vs Semax: What Can Researchers Compare?
| Research characteristic | Semax | Adamax |
|---|---|---|
| Peptide identity | Defined heptapeptide | Modified peptide designation |
| Published sequence data | Well documented | Verify against supplier analytical documentation |
| Peer-reviewed literature | Multiple published experimental studies | More limited under the Adamax name |
| Structural research | Extensively characterised relative to Adamax | Requires compound-specific verification |
| Appropriate comparison | Molecular and experimental measurements | Molecular and experimental measurements |
A comparison that is scientifically suitable should concentrate on the measurable laboratory properties rather than on the claimed results.
Column 1 Column 2 Column 3 Research characteristic Semax Adamax Peptide identity Defined heptapeptide Modified peptide designation Published sequence data Well documented Verify against supplier analytical documentation Peer-reviewed literature Multiple published experimental studies More limited under the Adamax name Structural research Extensively characterised relative to Adamax Requires compound-specific verification Appropriate comparison Molecular and experimental measurements Molecular and experimental measurements
What is Semax?
Semax is a synthetic heptapeptide whose amino acid sequence is Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP) and it consists of the ACTH(4–7) sequence followed by the C-terminal tripeptide Pro-Gly-Pro.
The Semax peptide has been studied in experimental work covering peptide chemistry, gene expression, protein expression and molecular signalling. For instance, laboratory studies have looked at the changes in neurotrophin-related gene expression and other molecular pathways after exposure to Semax in experimental models.
The findings refer to experiments and must not be taken as indicating that the results of the research will extend beyond the particular models in which they were obtained.
What is Adamax?
Adamax is a modified peptide related to Semax that is investigated in experimental peptide research.
While the research-peptide market refers to Adamax as a peptide derived from Semax, the amount of scientific literature listed under the name Adamax is much smaller than that available for Semax.
It is important to bear this distinction in mind when looking at the two compounds. The fact that a substance is designated as commercial or research-grade does not in itself prove that it has a standardized molecular structure or show that two peptides exhibit the same biochemical behaviour.
Researchers should therefore, when carrying out laboratory work, depend on the recorded sequence, molecular characteristics and analytical data connected with the particular material under examination rather than simply assuming that it is the same on the basis of its name.
Why Does Peptide Structure Matter?
Minor structural changes can lead to a modification of the physicochemical and biochemical behavior of peptides.
Semax serves as a useful example since research into compounds similar to Semax has found that altering the amino acid at its N-terminus can change its susceptibility to degradation by aminopeptidases.
An independent study looking into N-terminal acetylation has likewise shown that a change in structure can affect Semax's coordination chemistry with metal ions.
What these studies show is a more general rule in the field of peptide chemistry, namely that peptides which are structurally related should each be examined separately rather than being assumed to act in the same way.
How Can Structural Differences Be Investigated?
Researchers can use analytical and biochemical methods which are designed to measure certain properties in order to examine related peptides.
- Chromatographic analysis can assess sample purity and detect impurities or degradation products.
- Mass spectrometry can support molecular-identity verification by comparing experimentally measured mass with the expected molecular characteristics.
- Proteolytic-stability experiments can assess how rapidly peptide structures degrade under controlled conditions.
- Binding and molecular-interaction assays can investigate whether structural modification changes interactions with selected molecular targets.
- Gene- and protein-expression experiments can examine downstream molecular responses in defined experimental systems.
Importantly, results from one assay or experimental model should not automatically be extrapolated to another.
Why Is Analytical Verification Important?
Analytical verification helps establish that the material being studied corresponds to its stated identity.
In the field of peptide research, techniques including high performance liquid chromatography (HPLC) and mass spectrometry (MS) can be used to obtain details regarding purity and molecular identity. Such measurements are especially important when the peptides in question are modified or have been less thoroughly characterized.
When identifying the materials used in an experiment, analytical documentation should be assessed together with the published literature.
Adamax and Semax as Separate Research Compounds
Although Adamax and Semax can be considered together on account of their structural relationship, scientific comparisons should make a distinction between known information and assumptions drawn from their similarity.
Semax has a clearly documented sequence made up of seven amino acids and is the subject of a relatively large amount of experimental work. In contrast, Adamax is mentioned less frequently in peer-reviewed publications under that name.
For this reason, laboratory comparisons should be based on verified molecular identity, peptide structure, analytical characteristics, and directly measured experimental data rather than assumptions about equivalent biological activity.
Frequently Asked Questions about Semax and Adamax
On the other hand, treat them as separate research compounds and verify their molecular identities independently before carrying out the experimental comparison.
Semax has the sequence Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP).
They can be compared on the grounds of the supposed relationship in structure, enabling researchers to examine how molecular modification relates to observable differences under controlled experimental conditions.
Yes, experimental research on peptides of Semax analogs may indicate that structural modifications can affect properties such as proteolytic stability and metal-ion coordination.
By no means do structurally related peptides show the same physicochemical or biochemical properties, it therefore being necessary to carry out independent experimental characterization for each compound.
Researchers are able to compare the verified molecular identity, chromatographic behaviour, molecular mass, stability, molecular interactions and other measurable laboratory parameters under controlled conditions.
Scientific references
- 1 Tabbì G, et al. Semax, an ACTH4-10 peptide analog with high affinity for copper(II) ion and protective ability against metal induced cell toxicity. Journal of Inorganic Biochemistry. 2015. https://pubmed.ncbi.nlm.nih.gov/25310602/
- 2 Tabbì G, et al. Influence of the N-terminus acetylation of Semax, a synthetic analog of ACTH(4-10), on copper(II) and zinc(II) coordination and biological properties. 2016. https://pubmed.ncbi.nlm.nih.gov/27586814/
- 3 Dolotov OV, et al. Semax, an analog of ACTH(4-10), regulates BDNF and trkB expression in the rat hippocampus. Brain Research. 2006. https://pubmed.ncbi.nlm.nih.gov/16996037/
- 4 Medvedeva EV, et al. Semax, an analog of ACTH(4-7), regulates expression of immune response genes during ischemic brain injury in rats. Molecular Genetics and Genomics. 2017. https://pubmed.ncbi.nlm.nih.gov/28255762/
Research-use disclaimer: For research and laboratory use only. Not for human or animal consumption.
